Private limited company · Uccle · incorporated on 21/03/2018
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | -16,5 k € | +30.5% | -23,8 k € | -1159.4% | -1,9 k € | -106.8% | 27,9 k € | +510.9% | 4,6 k € | +122.6% | -20,3 k € | -128.9% | 70,1 k € | |
| EBITDA | -19,2 k € | +22.7% | -24,8 k € | -674.1% | -3,2 k € | -111.8% | 27,1 k € | +706.0% | 3,4 k € | +115.8% | -21,3 k € | -130.9% | 68,9 k € | |
| Operating profit | -19,6 k € | +25.5% | -26,3 k € | -254.2% | -7,4 k € | -142.1% | 17,6 k € | +420.0% | -5,5 k € | +80.0% | -27,5 k € | -145.3% | 60,8 k € | |
| Profit/loss | -23,0 k € | +44.8% | -41,8 k € | -142.1% | -17,3 k € | -196.5% | 17,9 k € | +479.5% | -4,7 k € | +84.1% | -29,7 k € | -157.9% | 51,3 k € | |
| Equity | -27,5 k € | -515.0% | -4,5 k € | -112.0% | 37,3 k € | -31.6% | 54,5 k € | +48.8% | 36,7 k € | -11.4% | 41,4 k € | -41.8% | 71,1 k € | |
| Total assets | 17,0 k € | -38.5% | 27,7 k € | -49.4% | 54,7 k € | -20.7% | 69,0 k € | +17.4% | 58,7 k € | +4.9% | 56,0 k € | -44.3% | 100,6 k € | |
| Cash | 3,0 k € | +248.3% | 862,6 € | -29.2% | 1,2 k € | -92.2% | 15,6 k € | -37.9% | 25,2 k € | +21.2% | 20,8 k € | -48.1% | 40,1 k € | |
| Debts | 44,5 k € | +38.5% | 32,1 k € | +84.8% | 17,4 k € | +20.6% | 14,4 k € | -34.7% | 22,1 k € | +52.3% | 14,5 k € | -50.0% | 29,0 k € | |
Source: Belgian Official Gazette
Private limited company loss-making in the latest fiscal year. Cash position rising (+248.3%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
OWIMED is a Private limited company incorporated in 2018. Its registered office is in Uccle.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.